Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment: a Double-blind Randomized Placebo-controlled Trial

NCT03024684 is registered in ClinicalTrials.gov with Chiayi Christian Hospital as lead sponsor.

NCT NCT03024684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03024684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment: a Double-blind Randomized Placebo-controlled Trial
Lead sponsor
Chiayi Christian Hospital
Phase
Phase 4
Overall status
Active, not recruiting
Start date
January 3, 2017
Completion date
January 31, 2027
Enrollment
240 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma